Training and Educational Opportunities

Inspiring and Training the Next Generation of Great Minds

MCI is committed to developing the next generation of outstanding researchers to continue the battle against cancer. We offer a variety of programs centered in basic and translational cancer biology research, including High School and Undergraduate Student Outreach, a Doctoral Program in Cancer Biology and a robust Postdoctoral Training Program.


Data in Progress

MCI also offers weekly Data in Progress presentations wherein postdoctoral students and Research Principal Investigators as well as guest researchers present the status of their current and on-going research. Data in Progress presentations are offered each Tuesday at 4:00-5:00 p.m. in the MCI Multipurpose Room.

Past Presentations

  • 05/02/17 -- DNA fiber Assay to Measure Fidelity and Dynamics of DNA Replication During Various Stress Conditions, Chinnadurai Mani, Ph.D.
  • 04/25/17 -- Complexity of the bone marrow microenvironment during malignant hematopoiesis, Robert S. Welner, Ph.D.
  • 04/19/17 -- ProteinSimple: Protein tools to assist researchers resolve protein analysis problems to reveal new insight into proteins and their role in disease, Simon Kratzat, Simple Western Sales Specialist
  • 04/18/17 -- Novel Isatin derivatives as anti-proliferative agents, Adam Keeton, Ph.D.
  • 04/11/17 -- TRIP12 regulation and modification of DNA polymerase beta, Qingming Fang, Ph.D.
  • 03/24/17 -- From the Bench to the Clinic, Dr. Andres Forero
  • 03/14/17 -- At the Crossroads Between Structural Biology and DNA Repair, Dr. Aishwarya Prakash 
  • 03/07/17 -- A new approach to understanding racial disparities in prostate cancer, Nallaisvam Palanisamy, Ph.D.
  • 02/21/17 -- Aberrant glycosylation of MUC16 enhances the malignant properties of pancreatic cancer cells, Prakash Radhakrishnan, Ph.D.
  • 02/17/17 -- Mitochondria matter: targeting mitochondrial function in tumor cells, Bennett Van Houten, Ph.D.
  • 01/24/17 -- Role of SON in Down Syndrome Acute Megakaryoblastic Leukemia, Eun-young Park, Ph.D.
  • 01/10/17 -- Risky Tanning Behaviors among Adolescents and Young Adults: Opportunities for Intervention and Prevention, Casey Daniel, Ph.D.
  • 01/03/17 -- SON-mediated alternative RNA splicing in glioblastoma, Dr. Jung-Hyun Kim
  • 12/20/16 -- Investigating tumor intrinsic functions of B7-H3 in ovarian cancer, Dr. Luciana Barnes
  • 12/06/16 -- IKK-epsilon promotes pancreatic tumor growth by modulating cancer metabolism through c-MYC, Haseeb Zubair, Ph.D.
  • 11/29/16 -- MYB rearrangements in head and neck adenoid cystic carcinoma, Mariana Brait, Ph.D.
  • 11/18/16 -- Small business funding at the National Cancer Institute: Helping scientific innovators move discoveries towards the marketplace, Kory Hallett, Ph.D., Program Manager, SBIR-National Cancer Institute
  • 11/15/16 -- UBE3B is a calmodulin-regulated, mitochondria-associated E3 ubiquitin ligase, Robert W. Sobol, Ph.D.
  • 11/08/16 -- Investigations of herbal medicines as adjuvants in chemotherapy, Greg Gorman, Ph.D.
  • 11/03/16 -- Radiotracer development for PET imaging of PDE10, Jinda Fan, Ph.D.
  • 10/25/16 -- The regulation and functional role of MALAT1, a long non-coding RNA, in breast cancer, Joshua Stone, Ph.D.
  • 10/18/16 -- Sunless tanning: A better alternative to indoor tanning?, Natalie Gassman, Ph.D.
  • 10/04/16 -- miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20, Zixing Liu, Ph.D.
  • 09/20/16 -- Rad6-mediated ubiquitin signaling in the etiology and therapeutics of ovarian cancer, Sebastian Spencer, Ph.D.
  • 09/06/16 -- An overview of then next generation high capacity cometchip DNA damage detection assay, Peter Sykora, Ph.D.
  • 08/09/16 -- Visualize the RNA World Next generation RNA ISH Technology, Arthur Haynes
  • 07/26/16 -- Chemopreventive role of silver nanoparticles (AgNPs) in UVB radiation-induced skin cancer, Nikhil Tyagi
  • 07/19/16 -- B7H3 regulates cancer stem cell through MVP signal transduction pathway, Zixing Liu, Ph.D.


Distinguished Scientist Seminar

MCI participates in the Distinguished Scientist Seminar series with the USA College of Medicine. National and international scientists and researchers are invited to host seminars that discuss their current and on-going research activities. Mitchell Cancer Institute sponsors several scientist/researchers during the year. Distinguished Scientist Seminars are offered on Thursdays at 4:00-5:00 p.m. in the first-floor auditorium at the USA College of Medicine's Medical Sciences Building.


Post-Doctoral Lunch & Learn Series:

Past Presentations

  • 03/29/17 -- "Alternative careers for PhDs: The lab is not your only option," presented by Andy Byrd & David Hinton, University of South Alabama, Office of Commercialization and Industry Collaborations
  • 12/08/16 -- "Financial Literacy: Creating a Roadmap for Success," presented by Matt McWhorter, Financial Services Professional, New York Life Securities
  • June 2016 -- "Career Paths in Science: Inside and Outside the Academic Track," presented by Kim Littlefield, PhD, Asst. Vice President, USA Research Development and Learning


Email Newsletters

Connect With Us